Total Funding
13
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
Michael Hanna: Founder, Director, Chairman Emeritus
Andrew L. Tussing: Co-Founder, COO & Corporate Secretary
About the Company
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases. It operates as a biotechnology company that develops OncoVAX, an Active Specific Immunotherapy (ASI) vaccine which uses the patient's own cancer cells to block the return of colon cancer following surgery.
The company was incorporated
in 2007 and is based in Frederick, Maryland.
